Zegocractin

Zegocractin (development code CM-4620) is a drug which acts as a selective inhibitor of the calcium channel ORAI1.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Zegocractin (development code CM-4620) is a drug which acts as a selective inhibitor of the calcium channel ORAI1. It inhibits store-operated calcium entry (SOCE) and has anti-inflammatory effects. It is being researched for the treatment of pancreatitis , including acute pancreatitis associated with systemic inflammatory response syndrome (completed phase 2b CARPO trial ).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1373868673 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.